Anaritide in acute tubular necrosis

New England Journal of Medicine

Volumn 336, Issue 12, 1997, Pages 828-834

  Allgren, Robin L ^a   Marbury, Thomas C ^b   Rahman, S Noor ^c   Weisberg, Lawrence S ^d   Fenves, Andrew Z ^e   Lafayette, Richard A ^f   Sweet, Richard M ^g   Genter, Fredric C ^a   Kurnik, Brenda R C ^d   Conger, John D ^h   Sayegh, Mohamed H ⁱ  

^a SCIOS INC   (United States)

^b ORLANDO CLINICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Department of Surgery   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g Kidney Disease and Critical Care Associates   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANARITIDE; AURICULIN; CREATININE; DIURETIC AGENT; DOPAMINE; PLACEBO; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OLIGURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ATRIAL NATRIURETIC FACTOR; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MIDDLE AGED; OLIGURIA; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 8044250898     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199703203361203     Document Type: Article

References (18)

1. Liano F, Garcia-Martin F, Gallego A, et al. Easy and early prognosis in acute tubular necrosis: a forward analysis of 228 cases. Nephron 1989;51: 307-13.
2. Corwin HL, Teplick RS, Schreiber MJ, Fang LS, Bonventre JV, Coggins CH. Prediction of outcome in acute renal failure. Am J Nephrol 1987;7:8-12.
3. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 1996;101:49-53.
4. Lanese DM, Yuan BH, Falk SA, Conger JD. The effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 1991;261: F1102-F1109.
5. Roy DR. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 1986;251:F220-F225.
6. Davis CL, Briggs JP. Effects of atrial natriuretic peptides on renal medullary solute gradients. Am J Physiol 1987;253:F679-F684.
7. Margulies KB, Burnett JC Jr. Atrial natriuretic factor modulates whole kidney tubuloglomerular feedback. Am J Physiol 1990;259:R97-R101.
8. Opgenorth TJ, Novosad EI. Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur J Pharmacol 1990;191:351-7.
9. Schafferhans K, Heidbreder E, Grimm D, Heidland A. Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 1986;44:240-4.
10. Nakamoto M, Shapiro JI, Shanley PF, Chan L, Schrier RW. In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 1987;80:698-705.
11. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A. Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987;80:1232-7.
12. Conger JD, Falk SA, Yuan BH, Schrier RW. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 1989;35:1126-32.
13. Conger JD, Falk SA, Hammond WS. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 1991;40:21-8.
14. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994;45:1731-8.
15. Fleming TR. Interpretation of subgroup analyses in clinical trials. Drug Inf J 1995;29:1681S-1687S.
16. Kelleher SP, Robinette JB, Miller F, Conger JD. Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 1987;31:725-30.
17. Manns M, Sigler MH, Teehan BP. Advantages of continuous venovenous hemodialysis (CVVHD) in acute renal failure. J Am Soc Nephrol 1995;6:470. abstract.
18. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331:1338-42.